What Is Driving the Q2 Recovery in FMCG and Pharma Majors?
Bikaji Foods Q2 FY26 Highlights
Net Profit: ₹79.77 Cr ↑16% YoY | ↑33% QoQ
Revenue: ₹830 Cr ↑15% YoY | ↑27% QoQ
EBITDA: ₹127.95 Cr ↑20% YoY | ↑33% QoQ
Margins: 15.42% vs 14.82% (YoY)
Godrej Industries Q2 FY26 Snapshot
Net Profit: ₹242 Cr ↓16% YoY | ↓31% QoQ
Revenue: ₹5,032 Cr ↑14% YoY | ↑5% QoQ
EBITDA: ₹134.3 Cr ↓77% YoY | ↓66% QoQ
Margins: 2.67% vs 11.95% (YoY) | 8.9% (QoQ)
JB Chemicals Q2 FY26 Results
Net Profit: ₹207.82 Cr ↑19% YoY | ↑3% QoQ
Revenue: ₹1,084.9 Cr ↑8% YoY | ↓1% QoQ
EBITDA: ₹309.6 Cr ↑14% YoY | ↑3% QoQ
EBITDA Margin: 28.54% vs 27.04% (YoY) | 27.50% (QoQ)
Domestic pharma names like JB Chemicals outperformed peers with margin expansion aided by cost control, while FMCG leaders maintained steady sales growth. For short-term market positioning, explore 👉 Nifty Option Trade | BankNifty Option Trade.
Valiant Laboratories Q2 FY26 Overview
Net Profit: ₹0.2 Cr vs ₹4.74 Cr loss (YoY) | ↓89% QoQ
Revenue: ₹46.20 Cr ↑115% YoY | ↓1% QoQ
EBITDA: ₹0.07 Cr vs ₹6.7 Cr loss (YoY) | ↓97% QoQ
Margins: 0.15% vs (-31.46%) (YoY) | 5.13% (QoQ)
Amanta Healthcare Q2 FY26 Performance
Net Profit: ₹1.20 Cr ↓47% YoY | ↓66% QoQ
Revenue: ₹70.88 Cr ↑6% YoY | ↑9% QoQ
EBITDA: ₹14.64 Cr ↑6% YoY | ↓2% QoQ
Margins: 20.65% vs 20.79% (YoY) | 22.79% (QoQ)
Bafna Pharmaceuticals Q2 FY26 Summary
Net Profit: ₹3.12 Cr ↑20% YoY | ↓8% QoQ
Revenue: ₹35.46 Cr ↓12% YoY | ↑2% QoQ
EBITDA: ₹4.27 Cr ↑13% YoY | ↓15% QoQ
Margins: 12.04% vs 9.40% (YoY) | 14.59% (QoQ)
Mercury Laboratories Q2 FY26 Snapshot
Net Profit: ₹1.64 Cr ↑228% YoY | ↑64% QoQ
Revenue: ₹19 Cr ↑4% YoY | ↑5% QoQ
EBITDA: ₹2.12 Cr ↑62% YoY | ↓9% QoQ
Margins: 11.16% vs 7.20% (YoY) | 12.80% (QoQ)
Investor Takeaway
Consumer and pharma names continued to outperform broader markets with improving profitability and stable growth trends. Companies like Bikaji Foods and JB Chemicals show operational strength and brand-led expansion. More expert commentary available at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
